FDA Approval Adds Vericiguat (Verquvo) to HF Treatment Options ...Middle East

Medscape - News
The drug with a novel mechanism among HF meds is indicated for an especially high-risk group: patients with LVEF of 45% or less and a history of HF hospitalization or outpatient IV diuretic therapy. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approval Adds Vericiguat (Verquvo) to HF Treatment Options )

Apple Storegoogle play

Also on site :